DFX Intelligence
Private Credit Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
N•••• H••••••••• H•••••• A•
Pharmaceuticals, Biotechnology & Life Sciencesgroup grade Aon a schedule nowsponsor unattributed
Also written as: Biotechnology & Life Sciences; Common Stock; Pharmaceuticals
Principal held
at least $33.0M
sum of BDC pieces, a lower bound
Fair value
$40.5M
99c on cost, debt pieces
Unfunded
$6.2M
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
Feb 1, 2030
no dated debt inside 24 months
On the tape since
Sep 30, 2025
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| F• K•• C•••••• C••• | unstated lien unstated Pharmaceuticals, Biotechnology & Life Sciences 2 | $1.0M | $1.2M 100c | S+560 bp |
| F• K•• C•••••• C••• | unstated lien unstated Pharmaceuticals, Biotechnology & Life Sciences 1 | $1.0M | $1.2M 100c | S+700 bp |
| F• K•• C•••••• C••• | unstated lien unstated Pharmaceuticals, Biotechnology & Life Sciences 4 | $5.5M | $6.1M 98c | S+950 bp |
| F• K•• C•••••• C••• | unstated lien unstated | n/a | n/a | |
| F• K•• C•••••• C••• | unstated lien unstated Pharmaceuticals, Biotechnology & Life Sciences 3 | $25.5M | $28.6M 99c | S+950 bp |
| F• K•• C•••••• C••• | equity equity Common Stock | n/a | $3.4M 106c |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $33.0M | $37.1M | 99c | 0 |
| Mar 31, 2026 | 1 | $33.0M | $37.4M | 100c | 0 |
| Dec 31, 2025 | 1 | $2.0M | $2.4M | 100c | 0 |
| Sep 30, 2025 | 1 | $4.0M | $4.8M | 100c | 0 |
What changed
- Spread increasedJun 30, 2026
- Spread increasedMar 31, 2026
- Maturity extended (observed)Mar 31, 2026
- Maturity shortened (observed)Dec 31, 2025
- New borrower on a BDC scheduleSep 30, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- NIDDA HEALTHCAREderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Pharmaceuticals, Biotechnology & Life Sciencesreportedas one filer wrote it